Oragenics Inc. (OGEN) financial statements (2021 and earlier)

Company profile

Business Address 4902 EISENHOWER BLVD
TAMPA, FL 33634
State of Incorp. FL
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18206451016
Cash and cash equivalents18206451016
Receivables    000
Inventory, net of allowances, customer advances and progress billings    000
Inventory    000
Other undisclosed current assets1210000
Total current assets:19227461117
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment0000000
Total noncurrent assets:1000000
TOTAL ASSETS:20227461117
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2111111
Accounts payable111000 
Accrued liabilities000000 
Employee-related liabilities000000 
Other undisclosed accounts payable and accrued liabilities0001001
Debt0000000
Deferred compensation liability     00
Due to related parties     0 
Deferred revenue and credits  000
Other undisclosed current liabilities     (0)(0)
Total current liabilities:2111111
Noncurrent Liabilities
Long-term debt and lease obligation1      
Operating lease, liability1
Total noncurrent liabilities:1      
Total liabilities:3111111
Stockholders' equity
Stockholders' equity attributable to parent17216351016
Preferred stock766    
Common stock0000000
Common stock, share subscribed but unissued, subscriptions receivable   (0)   
Additional paid in capital13812610198928686
Accumulated deficit(127)(111)(101)(95)(88)(76)(70)
Total stockholders' equity:17216351016
TOTAL LIABILITIES AND EQUITY:20227461117

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues    111
Revenue, net  1  
Cost of revenue
(Cost of Goods and Services Sold)
    (0)(0)(0)
Gross profit:    111
Operating expenses(16)(10)(7)(9)(12)(6)(17)
Operating loss:(16)(10)(7)(9)(12)(6)(16)
Nonoperating income (expense)00(0)0(0)00
Investment income, nonoperating0000000
Other nonoperating income (expense)00000(0)0
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(16)(10)(7)(9)(12)(6)(16)
Other undisclosed income from continuing operations before income taxes0000000
Loss from continuing operations before income taxes:(16)(10)(7)(8)(12)(6)(16)
Income tax expense (benefit)(4)(2)10342 
Income (loss) from continuing operations:(19)(12)3(6)(7)(4)(16)
Income from discontinued operations   1   
Net income (loss):(19)(12)3(4)(7)(4)(16)
Other undisclosed net income (loss) attributable to parent42(10)(3)(4)(2) 
Net loss attributable to parent:(16)(10)(7)(7)(12)(6)(16)
Other undisclosed net loss available to common stockholders, basic (1)     
Net loss available to common stockholders, diluted:(16)(11)(7)(7)(12)(6)(16)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(19)(12)3(4)(7)(4)(16)
Comprehensive income (loss), net of tax, attributable to parent:(19)(12)3(4)(7)(4)(16)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: